Literature DB >> 16516163

Wnt inhibitory factor-1, a Wnt antagonist, is silenced by promoter hypermethylation in malignant pleural mesothelioma.

Sonny Batra1, Yihui Shi, Kristopher M Kuchenbecker, Biao He, Noemi Reguart, Iwao Mikami, Liang You, Zhidong Xu, Yu-Ching Lin, Geneviève Clément, David M Jablons.   

Abstract

Wnt inhibitory factor-1 (WIF-1) is a secreted protein that antagonizes Wnt signaling. We recently demonstrated the importance of aberrant activation of the Wnt signaling pathway in various cancers including malignant pleural mesothelioma. In this study, we revealed downregulated WIF-1 expression in cell lines and primary tissue when compared to normal mesothelial cell lines and adjacent pleura, respectively. We observed hypermethylation in four of four mesothelioma cell lines, but not in two normal mesothelial cell lines. In primary tissue samples, we observed methylation in three paired tumor specimens compared to their adjacent normal pleura and methylation in eight of nine unpaired tumor tissue samples. Taken together, our studies suggest that WIF-1 silencing due to its promoter hypermethylation is an important mechanism underlying the constitutively activated Wnt signaling in mesothelioma. New therapies toward inhibition of the Wnt pathway through WIF-1 might be promising for the future treatment of malignant mesothelioma.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16516163     DOI: 10.1016/j.bbrc.2006.02.084

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  20 in total

Review 1.  Preclinical studies identify novel targeted pharmacological strategies for treatment of human malignant pleural mesothelioma.

Authors:  Roberto E Favoni; Antonio Daga; Paolo Malatesta; Tullio Florio
Journal:  Br J Pharmacol       Date:  2012-05       Impact factor: 8.739

Review 2.  Epigenetic alterations of the Wnt signaling pathway in cancer: a mini review.

Authors:  Ljiljana Serman; Tamara Nikuseva Martic; Alan Serman; Semir Vranic
Journal:  Bosn J Basic Med Sci       Date:  2014-11-12       Impact factor: 3.363

3.  Polycomb complex PRC1 as gatekeeper of intestinal stem cell identity.

Authors:  Nicolas Léveillé; Louis Vermeulen
Journal:  Stem Cell Investig       Date:  2016-06-15

Review 4.  Cancer metastasis - tricks of the trade.

Authors:  Rabia Zeeshan; Zeeshan Mutahir
Journal:  Bosn J Basic Med Sci       Date:  2017-08-20       Impact factor: 3.363

5.  Hypomethylation reduced the aggressive potential of human malignant mesothelioma cells.

Authors:  N-Y Kim; M-C Kim; Y Kim
Journal:  Cancer Gene Ther       Date:  2016-11-18       Impact factor: 5.987

6.  WIF1, a Wnt pathway inhibitor, regulates SKP2 and c-myc expression leading to G1 arrest and growth inhibition of human invasive urinary bladder cancer cells.

Authors:  Yaxiong Tang; Anne R Simoneau; Wu-xiang Liao; Guo Yi; Christopher Hope; Feng Liu; Shunqiang Li; Jun Xie; Randall F Holcombe; Frances A Jurnak; Dan Mercola; Bang H Hoang; Xiaolin Zi
Journal:  Mol Cancer Ther       Date:  2009-01-27       Impact factor: 6.261

Review 7.  A Wnt survival guide: from flies to human disease.

Authors:  Andy J Chien; William H Conrad; Randall T Moon
Journal:  J Invest Dermatol       Date:  2009-01-29       Impact factor: 8.551

8.  The Wnt inhibitory factor 1 restoration in prostate cancer cells was associated with reduced tumor growth, decreased capacity of cell migration and invasion and a reversal of epithelial to mesenchymal transition.

Authors:  David S Yee; Yaxiong Tang; Xuesen Li; Zhongbo Liu; Yi Guo; Samia Ghaffar; Peter McQueen; Dash Atreya; Jun Xie; Anne R Simoneau; Bang H Hoang; Xiaolin Zi
Journal:  Mol Cancer       Date:  2010-06-23       Impact factor: 27.401

Review 9.  Pathogenesis of malignant pleural mesothelioma and the role of environmental and genetic factors.

Authors:  Shoshana J Weiner; Siyamek Neragi-Miandoab
Journal:  J Cancer Res Clin Oncol       Date:  2008-09-12       Impact factor: 4.553

10.  Promoter methylation and mRNA expression of DKK-3 and WIF-1 in hepatocellular carcinoma.

Authors:  Zhen Ding; Ye-Ben Qian; Li-Xin Zhu; Qi-Ru Xiong
Journal:  World J Gastroenterol       Date:  2009-06-07       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.